Invivyd : IVVD

IVVD

Stock Data

$1.52

$0.12 (8.57%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Invivyd Inc is a pioneering biopharmaceutical company based in Waltham, Massachusetts, dedicated to combating infectious diseases. With a sharp focus on antibody-based solutions, its flagship product, adintrevimab, is making strides in Phase 3 clinical trials for COVID-19 treatment and prevention. Beyond adintrevimab, Invivyd is advancing other monoclonal antibodies like VYD222 and VYD224 against SARS-CoV-2, and exploring potential defenses against seasonal influenza. The company, evolving from Adagio Therapeutics in 2022, collaborates with notable institutions like Adimab, LLC, and the Scripps Research Institute to push the boundaries of infectious disease prevention and treatment.

All Invivyd Articles

1 Article

Lee Jackson | Dec 22, 2025 at 8:12 AM EST

Here Are Monday’s Top Wall Street Analyst Research Calls: BlackSky Technology, Cummins, Lamb Watson, Ollie’s Bargain Outlet, Sealed Air, Volaris, and More

Pre-Market Stock Futures: Futures are trading higher as we get ready to start a holiday-shortened trading week after an outstanding…

Invivyd : IVVD

IVVD

$1.52

All Invivyd Articles

Here Are Monday’s Top Wall Street Analyst Research Calls: BlackSky Technology, Cummins, Lamb Watson, Ollie’s Bargain Outlet, Sealed Air, Volaris, and More

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Invivyd : IVVD

IVVD

$1.52

All Invivyd Articles

Here Are Monday’s Top Wall Street Analyst Research Calls: BlackSky Technology, Cummins, Lamb Watson, Ollie’s Bargain Outlet, Sealed Air, Volaris, and More

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened